GreenPine Signs Cooperation Agreement with Emcure
On 14th June 2019, Mr. Shen Zaikuan, the Chairman of Tianjin GreenPine Pharma Co., Ltd. (hereinafter referred to as “GreenPine”) visited Emcure Pharmaceuticals Ltd. (hereinafter referred to as “Emcure”), a reputed pharmaceutical company, at Pune, India, and signed a long-term cooperation agreement both for Finished Dosage Forms (FDF)& APIs. The partnership on FDF’s extends to both oral solids and Injectable including Oncologyinjectables.
The products will be manufactured at the state of art facilities of Emcure both in India& USA
Emcure aglobally renowned specialty pharma companywithworld-class infrastructure, technology, resources and plants both in India & United Statesand has one of the deepest pipelines in the industry with a focus on niche products and products with technology-barriers and has a high level vertical integration.
GreenPine and Emcure have reached a long term understanding on further strategic cooperation for importation ofhigh-quality medicines into China providingcost effective and reliable treatment options to doctors and patients on a sustained basis.